Stomach Neoplasms: all 2,914 studies
Page 30 of 30. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00003237Phase 2
- Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the EsophagusCompletedNCT00003192Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach CancerCompletedNCT00003172Phase 2
- Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachCompletedNCT00003157Phase 1
- Irinotecan in Treating Patients With Advanced Cancer of the StomachCompletedNCT00003137Phase 2
- Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2
- Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerCompletedNCT00003055Phase 2
- Interleukin-12 in Treating Patients With Cancer in the AbdomenCompletedNCT00003046Phase 1
- Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002883Phase 3
- Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerCompletedNCT00002783Phase 2
- High-Dose Chemotherapy in Treating Patients With Advanced Stomach CancerCompletedNCT00002722Phase 2
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach CancerCompletedNCT00002615Phase 3
- A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
- Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal CarcinomatosisCompletedNCT00001332Phase 1